In-depth cardiovascular and pulmonary assessments in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: A case series study

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
PHYSIOLOGICAL REPORTS, v.10, n.5, article ID e15201, 9p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We assessed PET-CT myocardial blood flow (MBF) using N-13 ammonia, brachial flow-mediated dilation, and cardiopulmonary exercise test in five post-discarged MIS-C survivors. None of the patients (median age: 9, range: 7-18 years; 3 females; 2 males) had preexisting pediatric chronic conditions. At the follow-up visit, two patients exhibited severe perfusion defect developed in the left ventricular cavity, suggesting extensive myocardial ischemia (MBF <2.0) and one patient showed persistent mild pericardial effusion. Others two patients demonstrated endothelial dysfunction. Nevertheless, all patients had lower predicted values in the VO2peak, VO2VAT, OUES, and O-2 Pulse (range: 35.2%-64.5%; 15.6%-38.2%; 1.0-1.3 L/min; 4-7 ml/beat), respectively. Our d suggested that previously health MIS-C patients had impaired MBF, endothelial dysfunction and lower cardiopulmonary capacity at follow-up analysis. Multidisciplinary further investigations should be conducted to reinforce these findings.
Palavras-chave
cardiovascular imaging, COVID-19, inflammation, MIS-C, children
Referências
  1. Ballin M, 2021, J INTERN MED, V290, P1112, DOI 10.1111/joim.13353
  2. Bateman TM, 2021, J NUCL CARDIOL, V28, P768, DOI 10.1007/s12350-021-02552-7
  3. Bongers BC, 2011, EUR J CARDIOV PREV R, V18, P384, DOI 10.1177/1741826710389390
  4. Centers for Disease Control and Prevention, 2020, MULT INFL SYNDR CHIL
  5. de Vries J, 2006, NUCL MED COMMUN, V27, P791, DOI 10.1097/01.mnm.0000237984.46844.42
  6. Duarte-Neto AN, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100850
  7. Farooqi KM, 2021, PEDIATRICS, V148, DOI 10.1542/peds.2021-051155
  8. Feldstein LR, 2020, NEW ENGL J MED, V383, P334, DOI 10.1056/NEJMoa2021680
  9. Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183
  10. Holder SM, 2021, HYPERTENSION, V77, P1469, DOI 10.1161/HYPERTENSIONAHA.120.15754
  11. Hossri CA, 2019, EUR J PREV CARDIOL, V26, P177, DOI 10.1177/2047487318807977
  12. Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019
  13. Penner J, 2021, LANCET CHILD ADOLESC, V5, P473, DOI 10.1016/S2352-4642(21)00138-3
  14. Singh TP, 2003, PEDIATR CARDIOL, V24, P138, DOI 10.1007/s00246-002-0282-5
  15. Thijssen DHJ, 2019, EUR HEART J, V40, P2534, DOI 10.1093/eurheartj/ehz350